Contact
Please use this form to send email to PR contact of this press release:
Roche and Prothena will Advance Prasinezumab into Late-Stage Clinical Development Study in Parkinson’s Disease
TO:
Please use this form to send email to PR contact of this press release:
Roche and Prothena will Advance Prasinezumab into Late-Stage Clinical Development Study in Parkinson’s Disease
TO: